CareDx Update Regarding Raymond James & Associates’ Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company has determined not to participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference scheduled for later today in light of scheduling conflicts. The company looks forward to providing its next corporate update in the near term.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.67
+5.78 (2.24%)
AAPL  353.08
+1.17 (0.33%)
AMD  506.48
+3.06 (0.61%)
BAC  48.88
-0.55 (-1.12%)
GOOG  279.55
+1.95 (0.70%)
META  613.02
-5.85 (-0.95%)
MSFT  502.55
-3.69 (-0.73%)
NVDA  152.14
-3.32 (-2.14%)
ORCL  114.24
-0.76 (-0.66%)
TSLA  380.38
+0.27 (0.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.